Skip to main
AVAH

AVAH Stock Forecast & Price Target

AVAH Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 11%
Buy 56%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Aveanna Healthcare Hldgs is expected to continue to benefit from their strong market position and preferred payor strategy, as they cater to an increasingly in-demand segment of the healthcare market. However, potential risks such as government reimbursement changes and nurse shortages may pose challenges in the future, despite the company's recent acquisition and updated guidance demonstrating their ability to navigate these obstacles. Overall, with their focus on providing high-quality in-home care, Aveanna Healthcare is well-positioned for success and growth in the healthcare industry.

Bears say

Aveanna Healthcare Hldgs is facing significant challenges due to its reliance on Medicaid reimbursements and its exposure to potential budget constraints. Despite generating good free cash flow and targeting higher-value preferred payor relationships, concerns around Medicaid-reimbursement have caused the stock to pull back. However, with a growing number and mix of high-value preferred payor arrangements and a strong value proposition for Medicaid managed care, Aveanna may be a long-term investment opportunity. However, risks related to government reimbursement, nurse availability, policy changes, and regulatory/audit issues must be closely monitored.

AVAH has been analyzed by 9 analysts, with a consensus rating of Buy. 11% of analysts recommend a Strong Buy, 56% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aveanna Healthcare Holdings (AVAH) Forecast

Analysts have given AVAH a Buy based on their latest research and market trends.

According to 9 analysts, AVAH has a Buy consensus rating as of Jul 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aveanna Healthcare Holdings (AVAH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.